Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Challenger Acquisitions reveals dates of first action film fan convention to be run by Star Sanctum

Fan conventions are enormously popular. Star Sanctum founder Jane Lowther has more than 20 years of project and event management experience
Superman costume worn under shirt
If Wolverine were to wear Superman's costume ...

Challenger Acquisitions Limited (LON:CHAL) said the first action film fan convention to be run by Star Sanctum will be held in May next year.

Star Sanctum is the name of the private company Challenger is backing; it is set to launch with a three-day event in London running from May 5-7.

READ: Challenger Acquisitions has "tremendous confidence" construction of NY Wheel project will recommence in the near-term

Star Sanctum will provide a select number of paying attendees with a chance to do all the usual fan convention stuff, such as attend seminars, get autographs and photos of the stars of recent action hero movies.

Challenger has provided a £100,000 loan agreement to Star Sanctum to support the launch of its first convention in London.

“Star Sanctum has identified a very unique and growing business opportunity; these events are incredibly popular and lucrative in North America, where there is a track record of success dating back to 1970,” said Mark Gustafson, the chief executive officer of Challenger.

 

View full CHAL profile View Profile

Challenger Acquisitions Limited Timeline

Related Articles

picture of observation wheel
July 25 2017
Reports from New York said the project is set for major delays after Mammoet-Starneth, the design/build contractor, downed tools in May

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use